搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
5 小时
Elli Lilly’s weight loss drug to be covered in Medicare insurance in US for THIS ...
Eli Lilly’s obesity drug Zepbound is now covered by Medicare for sleep apnea treatment, expanding access to the costly ...
Daily Independent
9 小时
Understanding the dangers of untreated sleep apnea
There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people with OSA don't sleep well, they are at a higher risk for motor vehicle ...
9 小时
Tessan Showcases Innovative New Flagship Products at CES 2025, Redefining Travel Charging ...
At the heart of CES 2025, amidst the buzzing energy of South Hall 1, Booth No. 30562, Tessan’s exhibition space has become a ...
10 小时
Nvidia's Jensen Huang is ‘dead wrong' about quantum computers, D-Wave CEO says
D-Wave Quantum shares plunged 36% on Wednesday after Nvidia CEO Jensen Huang suggested that quantum computers are decades away.
gastroenterologyadvisor
16 小时
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈